Essity AB (ESSITY-B.ST) is a leading global hygiene and health company with strong brands in tissue, personal care, and incontinence products. The company benefits from defensive demand, ongoing margin recovery from raw material cost tailwinds, and a restructuring program targeting €400 million in annual savings by 2025. With a solid balance sheet and a dividend yield of ~3.5%, Essity offers a compelling risk-reward profile for consumer compounder investors.
Key Catalysts (12 months):
- Margin expansion from lower pulp prices and cost savings.
- Continued growth in professional hygiene and emerging markets.
- Potential portfolio optimization (e.g., divestiture of non-core assets).
Key Risks:
- Raw material price volatility (pulp, energy).
- Intense competition and private label pressure.
Valuation: Essity trades at ~15x forward P/E, a discount to peers like Kimberly-Clark (~18x) and Procter & Gamble (~24x), with a similar growth profile and higher free cash flow yield (~6%).
Balance Sheet: Net debt/EBITDA of ~1.5x, investment-grade credit rating, and strong free cash flow generation support dividend growth and strategic investments.
Disclaimer: This is not financial advice. Investing involves risk, including loss of principal. Please conduct your own research.